NO20054157L - Formuleringer av venlafaksin med forsinket frigjoring - Google Patents

Formuleringer av venlafaksin med forsinket frigjoring

Info

Publication number: NO20054157L
Authority: NO; Norway
Prior art keywords: delayed; release; release venlafaxine; formulations; venlafaxine formulations
Prior art date: 2003-02-07

Application number

NO20054157A

Other languages

English (en)

Norwegian (no)

Other versions

NO20054157D0 (no

Inventor

Fjalar Johannsson

Birkir Arnason

Original Assignee

Actavis Group Hf

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-02-07

Filing date

2005-09-07

Publication date

2005-11-03

2003-02-07 Priority claimed from IS6710A external-priority patent/IS6710A/is

2004-02-05 Priority claimed from IS7143A external-priority patent/IS7143A/is

2005-09-07 Application filed by Actavis Group Hf filed Critical Actavis Group Hf

2005-09-07 Publication of NO20054157D0 publication Critical patent/NO20054157D0/no

2005-11-03 Publication of NO20054157L publication Critical patent/NO20054157L/no

Links

230000003111 delayed effect Effects 0.000 title abstract 3
PNVNVHUZROJLTJ-UHFFFAOYSA-N venlafaxine Chemical compound C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 PNVNVHUZROJLTJ-UHFFFAOYSA-N 0.000 title abstract 3
229960004688 venlafaxine Drugs 0.000 title abstract 3
238000009472 formulation Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1
239000003795 chemical substances by application Substances 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
239000007916 tablet composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Pain & Pain Management (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Psychiatry (AREA)
Medicinal Preparation (AREA)

NO20054157A 2003-02-07 2005-09-07 Formuleringer av venlafaksin med forsinket frigjoring NO20054157L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
IS6710A IS6710A (is)	2003-02-07	2003-02-07	Venlafaxín samsetningar með seinkaða losun
IS7143A IS7143A (is)	2004-02-05	2004-02-05	Venlafaxín samsetningar með seinkaða losun
PCT/IS2004/000003 WO2004069228A2 (fr)	2003-02-07	2004-02-09	Formules de venlafaxine a liberation prolongee

Publications (2)

Publication Number	Publication Date
NO20054157D0 NO20054157D0 (no)	2005-09-07
NO20054157L true NO20054157L (no)	2005-11-03

Family

ID=32852478

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20054157A NO20054157L (no)	2003-02-07	2005-09-07	Formuleringer av venlafaksin med forsinket frigjoring

Country Status (6)

Country	Link
US (1)	US20060246132A1 (fr)
EP (1)	EP1596837A2 (fr)
EA (1)	EA011579B1 (fr)
IS (1)	IS8011A (fr)
NO (1)	NO20054157L (fr)
WO (1)	WO2004069228A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2507685A1 (fr) *	2002-11-28	2004-06-10	Themis Laboratories Private Limited	Procede de fabrication de microperles a liberation prolongee contenant de la venlafaxine hci
CZ20033294A3 (cs) *	2003-12-03	2005-06-15	Zentiva, A.S.	Potahovaná tableta s obsahem venlafaxinu nebo jeho solí s řízeným uvolňováním
DK1711169T3 (da) *	2004-02-04	2007-09-17	Alembic Ltd	Coatede mikrodepottabletter med venlafaxinhydrochlorid
US20090175934A1 (en) *	2006-03-08	2009-07-09	Jubilant Organosys Ltd.	Extended Release Pharmaceutical Formulation of Venlafaxine and Method of Manufacturing the Same
CZ307916B6 (cs) *	2017-05-08	2019-08-21	mcePharma s. r. o.	Orodispergovatelná tableta s biodostupným kurkuminem a její použití
US20240374542A1 (en) *	2023-05-10	2024-11-14	Elite Pharmaceutical Solution Inc.	Oral dosage forms of metformin and preparation method thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6440457B1 (en) *	1993-05-27	2002-08-27	Alza Corporation	Method of administering antidepressant dosage form
PE57198A1 (es) *	1996-03-25	1998-10-10	American Home Prod	Formula de liberacion prolongada
EP1967185A1 (fr) *	1999-12-23	2008-09-10	Pfizer Products Inc.	Forme de dosage de médicament entraîné par un hydrogél
EP1474123A1 (fr) *	2002-01-03	2004-11-10	LEK Pharmaceuticals D.D.	Formulation pharmaceutique a liberation controlee contenant de la venlafaxine
US20030190352A1 (en) *	2002-03-28	2003-10-09	Synthon Bv	Compositions of venlafaxine base
IL149055A0 (en) *	2002-04-09	2002-11-10	Karma Pharm Ltd	Extended release composition comprising as active compound venlafaxine hydrochloride

2004
- 2004-02-09 EP EP04709317A patent/EP1596837A2/fr not_active Withdrawn
- 2004-02-09 EA EA200501262A patent/EA011579B1/ru unknown
- 2004-02-09 WO PCT/IS2004/000003 patent/WO2004069228A2/fr not_active Ceased
- 2004-02-09 US US10/544,624 patent/US20060246132A1/en not_active Abandoned
2005
- 2005-09-06 IS IS8011A patent/IS8011A/is unknown
- 2005-09-07 NO NO20054157A patent/NO20054157L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP1596837A2 (fr)	2005-11-23
NO20054157D0 (no)	2005-09-07
IS8011A (is)	2005-09-06
WO2004069228A2 (fr)	2004-08-19
EA011579B1 (ru)	2009-04-28
WO2004069228A3 (fr)	2004-09-16
US20060246132A1 (en)	2006-11-02
EA200501262A1 (ru)	2006-04-28

Similar Documents

Publication	Publication Date	Title
BRPI0517088A (pt)	2008-09-30	formulação de comprimido estável
MA51204B1 (fr)	2022-02-28	Formes pharmaceutiques comprenant un inhibiteur de la kallicréine plasmatique
NO20090175L (no)	2009-03-11	Stabile laquinimod sammensetninger
MY152692A (en)	2014-11-28	Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
NO20090295L (no)	2009-01-20	Substituerte heteroarylderivater
MX2009000884A (es)	2009-06-05	Derivados de piridizinona.
NO20070866L (no)	2007-04-13	Antivirale forbindelser.
NO20070224L (no)	2007-04-02	2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
UY32156A (es)	2010-04-30	Derivados sustituidos de la n2 - [1-(5 - fluoropirimidin -2-il) etil] - n4 - (1-metil - 1h-imidazol - 4 - il)) - pirimidina - 2,4 - diaminas y sus sales farmacéuticamente aceptables, proceso de preparación, composiciones conteniéndolos y aplicaciones.
MY151295A (en)	2014-04-30	Pyrimidyl indoline compound
EA200500203A1 (ru)	2005-08-25	Новый способ синтеза и новая кристаллическая форма агомелатина и фармацевтические композиции, которые её содержат
CU23616B7 (es)	2011-01-27	Forma cristalina gamma del clorhidrato de la ivabradina, su procedimiento de preparación y las composiciones farmacéuticas que las contienen
NO20090596L (no)	2009-04-01	Antivirale fosfinatforbindelser
MX2009004746A (es)	2009-05-22	Derivados de 1,2,4-triazol como inhibidores del receptor sigma.
DE602005014382D1 (de)	2009-06-18	2-pyrimidinyl-pyrazolopyridin-erbb-kinaseinhibitoren
NO20074544L (no)	2007-11-08	Inhibering av HER2-losriving med matriksmetalloproteaseantagonister
PT2310356E (pt)	2013-10-31	Derivados de adamantildiamida e a sua utilização
EA200970532A1 (ru)	2009-10-30	Фумаратная соль (альфа s, бета r)-6-бром-альфа-[2-(диметиламино)этил]-2-метокси-альфа-1-нафталенил-бета-фенил-3-хинолинэтанола
NO20043367L (no)	2004-08-13	Oralt farmasoytisk preparat
CU20060038A7 (es)	2008-06-30	Forma cristalina gamma-d del clorhidrato de la ivabradina, su procedimiento de preparación y las composiciones farmacéuticas que las contienen
GEP20135805B (en)	2013-04-10	1-(ARYLSULFONYL)-4-(PIPERAZIN-1-YL)-1H-BENZIMIDAZOLES AS δ-HYDROXYTRYPTAMINE-6 LIGANDS
UA91848C2 (ru)	2010-09-10	Применение соединений диосметина в лечении и предотвращении тромботическим патологиям
NO20055631L (no)	2005-11-29	Doseringsform inneholdende pantoprazol som aktiv ingrediens
NO20054157L (no)	2005-11-03	Formuleringer av venlafaksin med forsinket frigjoring
NO20073071L (no)	2007-06-15	Benzotiazolformuleringer og anvendelse av disse

Legal Events

Date	Code	Title	Description
2012-10-01	FC2A	Withdrawal, rejection or dismissal of laid open patent application